Prostate cancer detection with magnetic resonance‐ultrasound fusion biopsy: The role of systematic and targeted biopsies

The current study was conducted to evaluate the performance of magnetic resonance (MR)‐ultrasound‐guided fusion biopsy in diagnosing clinically significant prostate cancer (csCaP).

[1]  Xavier Leroy,et al.  Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading. , 2011, Urology.

[2]  Y. Yamashita,et al.  Negative predictive value of multiparametric MRI for prostate cancer detection: outcome of 5-year follow-up in men with negative findings on initial MRI studies. , 2014, European journal of radiology.

[3]  D. Margolis,et al.  Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply? , 2014, The Journal of urology.

[4]  Saila Kauppila,et al.  Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial. , 2016, European urology.

[5]  Jacob Sosna,et al.  MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. , 2004, Academic radiology.

[6]  Alzheimer's Disease Neuroimaging Initiative.  Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults , 2016 .

[7]  David Y. Lu,et al.  Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology. , 2014, The Journal of urology.

[8]  M. Vural,et al.  Multiparametric MRI guidance in first-time prostate biopsies: what is the real benefit? , 2015, Diagnostic and interventional radiology.

[9]  Mark Emberton,et al.  Can MRI replace serial biopsies in men on active surveillance for prostate cancer? , 2014, Current opinion in urology.

[10]  David Y. Lu,et al.  Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. , 2015, European urology.

[11]  M. Roobol,et al.  Active surveillance for low-risk prostate cancer worldwide: the PRIAS study. , 2013, European urology.

[12]  Pingkun Yan,et al.  Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. , 2011, The Journal of urology.

[13]  Aaron Fenster,et al.  Clinical application of a 3D ultrasound-guided prostate biopsy system. , 2011, Urologic oncology.

[14]  E. Metter,et al.  Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. , 2007, The Journal of urology.

[15]  K. Wallner,et al.  Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting , 2009, Prostate Cancer and Prostatic Diseases.

[16]  Silvia D. Chang,et al.  Multiparametric magnetic resonance imaging-targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results. , 2015, Urologic oncology.

[17]  Dan Stoianovici,et al.  Geometric evaluation of systematic transrectal ultrasound guided prostate biopsy. , 2012, The Journal of urology.

[18]  Baris Turkbey,et al.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. , 2015, JAMA.

[19]  P. Ochodnický,et al.  Autonomic nervous control of the urinary bladder , 2013, Acta physiologica.

[20]  Baris Turkbey,et al.  Comparison of endorectal coil and nonendorectal coil T2W and diffusion‐weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole‐mount histopathology , 2014, Journal of magnetic resonance imaging : JMRI.

[21]  P. Walsh,et al.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.

[22]  P. Choyke,et al.  Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer , 2013, Cancer.

[23]  A. Kibel.  Accuracy of Multiparametric Magnetic Resonance Imaging in Confirming Eligibility for Active Surveillance for Men With Prostate Cancer , 2014 .

[24]  B. K. Park,et al.  Comparison of Phased-Array 3.0-T and Endorectal 1.5-T Magnetic Resonance Imaging in the Evaluation of Local Staging Accuracy for Prostate Cancer , 2007, Journal of computer assisted tomography.

[25]  H. Ahmed,et al.  The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—Can it rule out clinically significant prostate cancer? , 2014, Urologic oncology.

[26]  Jurgen J Fütterer,et al.  Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. , 2014, AJR. American journal of roentgenology.

[27]  Shyam Natarajan,et al.  Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. , 2013, The Journal of urology.

[28]  T. Kessler,et al.  Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses. , 2012, European urology.

[29]  PI-RADS v 2 Prostate Imaging and Report and Data System : Version 2 , 2022 .

[30]  F. Montorsi,et al.  Dismiss Systematic Transrectal Ultrasound-guided and Embrace Targeted Magnetic Resonance Imaging-informed Prostate Biopsy: Is the Paradigm Ready to Shift? , 2016, European urology.

[31]  Shyam Natarajan,et al.  Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. , 2014, European urology.

[32]  M Emberton,et al.  Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard , 2013, Prostate Cancer and Prostatic Disease.